Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28 | 211 | 19 | 51 | 86 |
| Marketable Securities | N/A | N/A | N/A | 1,503 | 2,376 |
| Other current assets | 21 | 18 | 1,040 | 20 | 75 |
| TOTAL | $49 | $229 | $1,059 | $1,574 | $2,537 |
| Non-Current Assets | |||||
| PPE Net | 3 | 2 | N/A | 74 | 526 |
| Other Non-Current Assets | 47 | 81 | 124 | 188 | 694 |
| TOTAL | $50 | $83 | $124 | $262 | $1,220 |
| Total Assets | $99 | $312 | $1,183 | $1,836 | $3,757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 94 | 10 | 23 | 21 | 24 |
| Accounts payable and accrued liabilities | 149 | 88 | 344 | 48 | 145 |
| Accrued Expenses | 89 | 92 | 158 | 83 | N/A |
| Other current liabilities | N/A | N/A | 106 | N/A | N/A |
| TOTAL | $1,288 | $1,023 | $1,141 | $490 | $458 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 10 | 32 | 53 |
| Other Non-Current Liabilities | 743 | 792 | 856 | 941 | 796 |
| TOTAL | $743 | $792 | $866 | $973 | $849 |
| Total Liabilities | $2,031 | $1,815 | $2,007 | $1,463 | $1,308 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,065 | 26,926 | 22,649 | 22,291 | N/A |
| Common Shares | 41 | 26 | 22 | 22 | 22 |
| Retained earnings | -12,510 | -10,762 | -9,694 | -8,486 | -6,406 |
| TOTAL | $-1,932 | $-1,503 | $-824 | $374 | $2,450 |
| Total Liabilities And Equity | $99 | $312 | $1,183 | $1,836 | $3,757 |